A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma.
Phase of Trial: Phase III
Latest Information Update: 03 May 2012
At a glance
- Drugs Insulin; Insulin
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 03 May 2012 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 03 May 2012 Actual patient number is 3 according to ClinicalTrials.gov.